Hepatitis C infection in children and adolescents with end-stage renal disease

被引:4
作者
Molle, ZL
Baqi, N
Gretch, D
Hidalgo, G
Tejani, A
Rabinowitz, SS
机构
[1] Long Isl Coll Hosp, Dept Pediat Gastroenterol & Nutr, Brooklyn, NY 11201 USA
[2] Sunnybrook Hlth Sci Ctr, Div Pediat Gastroenterol & Nutr, Brooklyn, NY USA
[3] Sunnybrook Hlth Sci Ctr, Div Pediat Nephrol, Brooklyn, NY USA
[4] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA
[5] New York Med Coll, Dept Pediat & Surg, Valhalla, NY 10595 USA
关键词
hepatitis C; end-stage renal disease; hemodialysis; liver disease;
D O I
10.1007/s00467-002-0845-y
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The prevalence of hepatitis C virus (HCV) infection and the risk factors associated with its transmission are described in a contemporary cohort of 55 children and adolescents with end-stage renal disease (ESRD). Thirty-seven patients were on dialysis or had been transplanted (ESRD) and 18 had chronic renal failure (CRF) but had not yet received dialysis. Seven (19%) tested positive for HCV by enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), or both. None of the children with CRF were infected. HCV infection was associated with length of time on dialysis, but not with age, gender, race, or units of blood transfused. These data corroborate earlier reports and confirm that children with ESRD continue to have a high prevalence of HCV. It is also shown for the first time that elevated transaminases should not be employed to predict HCV infection in this cohort, as all affected children had normal serum levels. Because of unique characteristics in this cohort, both ELISA and PCR are required to maximize HCV diagnostic sensitivity. Although HCV remains an important consideration in pediatric ESRD, the present study shows that recent advances in clinical practice have eliminated one of the major ways in which it was previously being transmitted.
引用
收藏
页码:444 / 449
页数:6
相关论文
共 28 条
[1]   NEW INSIGHTS INTO HEPATITIS-C VIRUS-INFECTION OF HEMODIALYSIS-PATIENTS - THE IMPLICATIONS [J].
ALMESHARI, K ;
ALAHDAL, M ;
ALFURAYH, O ;
ALI, A ;
DEVOL, E ;
KESSIE, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (04) :572-578
[2]   EPIDEMIOLOGY OF HEPATITIS-C IN THE WEST [J].
ALTER, MJ .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :5-14
[3]  
BILGIN N, 1993, TRANSPLANT P, V25, P3261
[4]  
Canero-Velasco Maria Cristina, 1998, Acta Gastroenterologica Latinoamericana, V28, P265
[5]  
CHENG IKP, 1993, TRANSPLANT P, V25, P1460
[6]   THE DECLINING RISK OF POSTTRANSFUSION HEPATITIS-C VIRUS-INFECTION [J].
DONAHUE, JG ;
MUNOZ, A ;
NESS, PM ;
BROWN, DE ;
YAWN, DH ;
MCALLISTER, HA ;
REITZ, BA ;
NELSON, KE .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (06) :369-373
[7]   QUANTITATION OF HEPATITIS-C VIRAL-RNA IN SERA OF HEMODIALYSIS-PATIENTS - GENDER-RELATED DIFFERENCES IN VIRAL LOAD [J].
DUBOIS, DB ;
GRETCH, D ;
DELAROSA, C ;
LEE, W ;
FINE, J ;
BLAGG, CR ;
COREY, L .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (05) :795-801
[8]   DETECTION OF HEPATITIS-C INFECTION BY POLYMERASE CHAIN-REACTION AMONG HEMODIALYSIS-PATIENTS [J].
DUSSOL, B ;
CHICHEPORTICHE, C ;
CANTALOUBE, JF ;
ROUBICEK, C ;
BIAGINI, P ;
BERTHEZENE, P ;
BERLAND, Y .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (04) :574-580
[9]  
Garcia G, 1995, Semin Gastrointest Dis, V6, P35
[10]   HEPATITIS-C VIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS - EPIDEMIOLOGY, CLINICAL IMPACT, SEROLOGICAL CONFIRMATION AND VIRAL REPLICATION [J].
GENESCA, J ;
VILA, J ;
CORDOBA, J ;
SAULEDA, S ;
QUER, J ;
ESTEBAN, JI ;
ESTEBAN, R ;
PIERA, L ;
GUARDIA, J .
JOURNAL OF HEPATOLOGY, 1995, 22 (03) :272-277